Efficacy and safety of sibeprenlimab in IgA nephropathy: a systematic review and meta-analysis of randomized controlled trials
Abstract Background IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. A Proliferation-Inducing Ligand (APRIL) plays a critical role in the development and progression of IgAN. This study aimed to evaluate the efficacy and safety of sibeprenlimab, an APRIL receptor antag...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2026-03-01
|
| Серии: | BMC Nephrology |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s12882-026-04927-9 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|